Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
alpha-lipoic acid (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
HIV Infections (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Trials (1 total)
Trial APIs (1 total)